시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 사시 및 약시 디지털 치료제 시장 보고서(2025년)
Strabismus And Amblyopia Digital Therapeutics Global Market Report 2025
상품코드 : 1760723
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

사시 및 약시 디지털 치료제 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 11.1%의 연평균 복합 성장률(CAGR)로 9억 3,000만 달러 규모에 이를 것으로 예측됩니다. 예측 기간 동안의 성장은 사시 및 약시 유병률 증가, 비침습적 치료에 대한 수요 증가, 원격 의료 및 원격 치료에 대한 접근성 향상, 조기 발견 및 개입에 대한 관심 증가, 고령화 등에 기인할 것으로 예측됩니다. 이 기간 동안 예상되는 주요 동향으로는 디지털 치료 기술의 발전, 눈 건강을 위한 디지털 앱의 디자인 개선, 기술 기업과 의료 서비스 제공업체 간의 협력, 안과 의료에서 웨어러블 기기의 채택, 안과 질환의 디지털 진단 강화 등이 있습니다.

텔레헬스의 지속적인 확대는 사시 및 약시 디지털 치료제 시장의 성장을 크게 촉진할 것으로 예측됩니다. 원격의료는 디지털 통신 기술을 이용하여 의료 서비스, 진료, 모니터링을 원격으로 제공하는 것으로, 특히 원격지나 의료 서비스가 부족한 지역의 환자들의 의료 접근을 용이하게 해줍니다. 이러한 성장은 헬스케어에 대한 접근성 증가에 기인하며, 환자는 전문가와 상담하고 여행이나 직접 방문하지 않고도 진료를 받을 수 있습니다. 사시(눈의 위치가 어긋나거나 약시(흐릿한 눈)와 같은 증상의 경우, 원격 의료는 지속적인 원격 모니터링과 감시를 가능하게 함으로써 디지털 치료를 강화합니다. 이는 특히 어린이에게 유익하며, 집에서 지속적으로 모니터링되는 치료를 받을 수 있기 때문에 특히 유용합니다. 디지털 헬스 기업 Rock Health에 따르면, 2022년 기준 미국 성인의 80%가 원격 의료를 이용하고 있으며, 이는 2021년 72%에서 8% 포인트 증가한 수치입니다. 이러한 원격 의료 서비스에 대한 의존도 증가는 사시-약시 디지털 치료제 시장을 앞당길 것으로 보입니다.

사시 및 약시 디지털 치료제 시장의 주요 업체들은 눈의 협응력과 시력을 향상시키는 인터랙티브 운동을 사용하는 첨단 디지털 치료 기기 개발에 주력하고 있습니다. 이러한 장치는 디지털 플랫폼을 통해 치료 중재를 제공하며, 기존 방식에 비해 더 매력적이고 개인화된 경우가 많습니다. 예를 들어, 2022년 4월 이스라엘에 본사를 둔 의료기기 회사 노바사이트(NovaSight)는 미국 식품의약국(FDA)으로부터 큐어사이트(CureSight)가 승인을 받았다고 발표했습니다. 큐어사이트는 시선 추적 훈련을 통해 시력과 입체시를 향상시키고 약시를 치료하기 위해 설계된 디지털 치료기입니다. 양방향 시각 운동을 제공함으로써 양안 협응력을 향상시키는 것을 목표로 합니다. 이 장치는 4세에서 9세 아동 103명을 대상으로 한 다기관 무작위 대조 시험에서 유효성이 입증되었으며, 그 결과 기존 아이패치법 대비 시력 개선 효과가 우수한 것으로 입증되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Strabismus and amblyopia digital therapeutics are software-based medical treatments designed to address visual misalignment and impaired vision through interactive, technology-driven platforms. These therapies are often customized to meet individual needs and progress, fostering visual improvement through consistent use and remote monitoring.

The main types of digital therapeutics for strabismus and amblyopia include both software and hardware. Software-based digital therapeutics are applications specifically developed to treat eye conditions such as strabismus (crossed eyes) and amblyopia (lazy eye). These treatments are commonly used in hospitals, ophthalmic clinics, and other healthcare settings.

The strabismus and amblyopia digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides strabismus and amblyopia digital therapeutics market statistics, including strabismus and amblyopia digital therapeutics industry global market size, regional shares, competitors with a strabismus and amblyopia digital therapeutics market share, detailed strabismus and amblyopia digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the strabismus and amblyopia digital therapeutics industry. This strabismus and amblyopia digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The strabismus and amblyopia digital therapeutics market size has grown rapidly in recent years. It will grow from $0.55 billion in 2024 to $0.61 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth during the historic period can be attributed to increased research and development in digital eye therapy, government support for healthcare innovation, expanding health insurance coverage for digital health solutions, a growing focus on personalized medicine, and heightened awareness of amblyopia and strabismus.

The strabismus and amblyopia digital therapeutics market size is expected to see rapid growth in the next few years. It will grow to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth during the forecast period can be attributed to the rising prevalence of strabismus and amblyopia, growing demand for non-invasive treatments, better access to telemedicine and remote care, an increasing focus on early detection and intervention, and an aging population. Key trends expected during this period include advancements in digital therapeutics technology, improvements in the design of digital apps for eye health, collaboration between technology companies and healthcare providers, the adoption of wearable devices in eye care, and enhancements in digital diagnostics for eye conditions.

The ongoing expansion of telehealth is expected to significantly drive the growth of the strabismus and amblyopia digital therapeutics market. Telehealth involves the use of digital communication technologies to provide healthcare services, consultations, and monitoring remotely, facilitating access to healthcare for patients, particularly in remote or underserved regions. This growth is largely due to the increasing accessibility of healthcare, which enables patients to consult with specialists and receive care without the need for travel or in-person visits. For conditions such as strabismus (misalignment of the eyes) and amblyopia (lazy eye), telehealth enhances digital therapeutics by allowing for continuous remote monitoring and supervision. This is especially beneficial for children, as they can receive consistent, supervised therapy from home. According to Rock Health, a digital health company, 80% of U.S. adults had accessed care via telemedicine as of 2022, an 8 percentage point increase from 72% in 2021. This growing reliance on telehealth services is set to propel the strabismus and amblyopia digital therapeutics market forward.

Leading companies in the strabismus and amblyopia digital therapeutics market are focusing on the development of advanced digital therapy devices that use interactive exercises to improve eye coordination and visual acuity. These devices deliver therapeutic interventions via digital platforms, which are often more engaging and personalized compared to traditional methods. For example, in April 2022, NovaSight, an Israel-based medical device company, announced that its CureSight device received clearance from the U.S. Food and Drug Administration (FDA). CureSight is a digital therapy device designed to treat amblyopia by enhancing visual and stereo acuity through eye-tracking exercises. It trains both eyes to work together by providing interactive visual exercises, aiming to improve collaboration between the eyes. The device was shown to be effective in a multicenter, randomized, controlled study involving 103 children aged 4 to 9, with results demonstrating positive improvements in visual acuity compared to conventional eye patching methods.

In March 2025, Pentec Health Inc., a U.S.-based healthcare company, partnered with Luminopia Inc. to expand the market reach of Luminopia's digital therapeutics for amblyopia and mild strabismus. This strategic partnership aims to enhance the distribution and accessibility of digital therapeutic solutions, improving patient outcomes and making treatments more widely available. Luminopia Inc. is known for its innovative approach to treating amblyopia and strabismus using interactive digital therapeutics, focusing on improving visual function through a more engaging and less invasive approach compared to traditional methods such as patching.

Major players in the strabismus and amblyopia digital therapeutics market are 3M Company, Freedom Scientific Inc., Ocutrx Vision Technologies LLC, Orthoptics Australia Inc., Good-Lite Company, AmblyoPlay, NovaSight Ltd., Luminopia Inc., NeuraSim Health, Bynocs Inc., RevitalVision LLC, Vivid Vision Inc., Binovi Technologies Corp., Wow Vision Therapy, OculoMotor Technologies Inc., Web Vision Therapy, CureSee Vision Therapy, AnteoTech Ltd, VisionBuilder, HTS Vision Therapy Systems.

North America was the largest region in the strabismus and amblyopia digital therapeutics market in 2024. The regions covered in strabismus and amblyopia digital therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the strabismus and amblyopia digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The strabismus and amblyopia digital therapeutics market consists of revenues earned by entities by providing services such as digital vision therapy programs, remote patient monitoring, gamified therapeutic exercises, teleconsultation and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The strabismus and amblyopia digital therapeutics market also includes sales of tablet-based therapy kits, eye-tracking devices, therapy management dashboards and vision assessment tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Strabismus And Amblyopia Digital Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on strabismus and amblyopia digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for strabismus and amblyopia digital therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The strabismus and amblyopia digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Strabismus And Amblyopia Digital Therapeutics Market Characteristics

3. Strabismus And Amblyopia Digital Therapeutics Market Trends And Strategies

4. Strabismus And Amblyopia Digital Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Strabismus And Amblyopia Digital Therapeutics Growth Analysis And Strategic Analysis Framework

6. Strabismus And Amblyopia Digital Therapeutics Market Segmentation

7. Strabismus And Amblyopia Digital Therapeutics Market Regional And Country Analysis

8. Asia-Pacific Strabismus And Amblyopia Digital Therapeutics Market

9. China Strabismus And Amblyopia Digital Therapeutics Market

10. India Strabismus And Amblyopia Digital Therapeutics Market

11. Japan Strabismus And Amblyopia Digital Therapeutics Market

12. Australia Strabismus And Amblyopia Digital Therapeutics Market

13. Indonesia Strabismus And Amblyopia Digital Therapeutics Market

14. South Korea Strabismus And Amblyopia Digital Therapeutics Market

15. Western Europe Strabismus And Amblyopia Digital Therapeutics Market

16. UK Strabismus And Amblyopia Digital Therapeutics Market

17. Germany Strabismus And Amblyopia Digital Therapeutics Market

18. France Strabismus And Amblyopia Digital Therapeutics Market

19. Italy Strabismus And Amblyopia Digital Therapeutics Market

20. Spain Strabismus And Amblyopia Digital Therapeutics Market

21. Eastern Europe Strabismus And Amblyopia Digital Therapeutics Market

22. Russia Strabismus And Amblyopia Digital Therapeutics Market

23. North America Strabismus And Amblyopia Digital Therapeutics Market

24. USA Strabismus And Amblyopia Digital Therapeutics Market

25. Canada Strabismus And Amblyopia Digital Therapeutics Market

26. South America Strabismus And Amblyopia Digital Therapeutics Market

27. Brazil Strabismus And Amblyopia Digital Therapeutics Market

28. Middle East Strabismus And Amblyopia Digital Therapeutics Market

29. Africa Strabismus And Amblyopia Digital Therapeutics Market

30. Strabismus And Amblyopia Digital Therapeutics Market Competitive Landscape And Company Profiles

31. Strabismus And Amblyopia Digital Therapeutics Market Other Major And Innovative Companies

32. Global Strabismus And Amblyopia Digital Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Strabismus And Amblyopia Digital Therapeutics Market

34. Recent Developments In The Strabismus And Amblyopia Digital Therapeutics Market

35. Strabismus And Amblyopia Digital Therapeutics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기